參考文獻(xiàn)/References:
[1] VISSER A W,IOAN-FACSINAY A,DE MUTSERT R,et al.Adiposity and hand osteoarthritis:the Netherlands epidemiology of obesity study[J].Arthritis Res Ther,2014,16(1):R19.
[2] KUNDU P,BLACHER E,ELINAV E,et al.Our gut microbiome:the evolving inner self[J].Cell,2017,171(7):1481-1493.
[3] BENSON A K,KELLY S A,LEGGE R,et al.Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors[J].Proc Natl Acad Sci USA,2010,107(44):18933-18938.
[4] BLANEY DAVIDSON EN,VAN CAAM A P,VAN DER KRAAN P M.Osteoarthritis year in review 2016:biology[J].Osteoarthritis Cartilage,2017,25(2):175-180.
[5] FRIDRICH F,BáCA V,DZUPA V.Infectious inflammation of pubic symphysis(symphysitis pubis purulenta):five case reports and literature view[J].Acta Chir Orthop Traumatol Cech,2016,83(6):411-417.
[6] ZHANG J,CHEN S L,LI L B.Correlation between intestinal flora and serum inflammatory factors in patients with Crohn’s disease[J].Eur Rev Med Pharmacol Sci,2017,21(21):4913-4917.
[7] MIURA K,ISHIOKA M,IIJIMA K.The roles of the gut microbiota and Toll-like receptors in obesity and nonalcoholic fatty liver disease[J].J Obes Metab Syndr,2017,26(2):86-96.
[8] GUSS J D,ZIEMIAN S N,LUNA M,et al.The effects of metabolic syndrome,obesity,and the gut microbiome on load-induced osteoarthritis[J].Osteoarthritis Cartilage,2019,27(1):129-139.
[9] NAGPAL R,KUMAR M,YADAV A K,et al.Gut microbiota in health and disease:an overview focused on metabolic inflammation[J].Benef Microbes,2016,7(2):181-194.
[10] HOTAMISLIGIL G S.Inflammation,metaflammation and immunometabolic disorders[J].Nature,2017,542(7640):177-185.
[11] FENG X B,JIANG J,LI M,et al.Role of intestinal flora imbalance in pathogenesis of pouchitis[J].Asian Pac J Trop Med,2016,9(8):786-790.
[12] HASENOEHRL C,TASCHLER U,STORR M,et al.The gastrointestinal tract-a central organ of cannabinoid signaling in health and disease[J].Neurogastroenterol Motil,2016,28(12):1765-1780.
[13] DANIELS J,DESHPANDE V,SERRA S,et al.Incidental single-organ vasculitis of the gastrointestinal tract:an unusual form of single-organ vasculitis with coexistent pathology[J].Pathology,2017,49(6):661-665.
[14] SCHOTT E M,FARNSWORTH C W,GRIER A,et al.Targeting the gut microbiome to treat the osteoarthritis of obesity[J].JCI Insight,2018,3(8):e95997.
[15] HORTA-BAAS G,ROMERO-FIGUEROA M D S,MONTIEL-JARQUIN A J,et al.Intestinal dysbiosis and rheumatoid arthritis:a link between gut microbiota and the pathogenesis of rheumatoid arthritis[J].J Immunol Res,2017(Special Issue):4835189.
[16] BACKHED F,DING H,WANG T,et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proc Natl Acad Sci USA,2004,101(44):15718-15723.
[17] SCHNEEBERGER M,EVERARD A,GóMEZ-VALADS A G,et al.Akkermansia muciniphila inversely correlates with the onset of inflammation,altered adipose tissue metabolism and metabolic disorders during obesity in mice[J].Sci Rep5,2015,5:16643.
[18] BODEN G.Obesity and free fatty acids[J].Endocrinol Metab Clin North Am,2008,37(3):635-646.
[19] RODRíGUEZ-CARRIO J,SALAZAR N,MARGOLLES A,et al.Free fatty acids profiles are related to gut microbiota signatures and short-chain fatty acids[J].Front Immunol,2017,8:823.
[20] KIM S,HWANG J,KIM J,et al.Metabolite profiles of synovial fluid change with the radiographic severity of knee osteoarthritis[J].Joint Bone Spine,2017,84(5):605-610.
[21] LEE S W,RHO J H,LEE S Y,et al.Dietary fat-associated osteoarthritic chondrocytes gain resistance to lipotoxicity through PKCK2/STAMP2/FSP27[J].Bone Res,2018,6:20.
[22] LIPPIELLO L,WALSH T,FIENHOLD M.The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage[J].Metabolism,1991,40(6):571-576.
[23] CANI P D,AMAR J,IGLESIAS M A,et al.Metabolic endotoxemia initiates obesity and insulin resistance[J].Diabetes,2007,56(7):1761-1772.
[24] CHI W,DAO D,LAU T C,et al.Bacterial peptidoglycan stimulates adipocyte lipolysis via NOD1[J].PLoS One,2014,9(5):e97675.
[25] WOLF A J,UNDERHILL D M.Peptidoglycan recognition by the innate immune system[J].Nat Rev Immunol,2018,18(4):243-254.
[26] VAN DER HEIJDEN I M,WILBRINK B,TCHETVERIKOV I,et al.Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides[J].Arthritis Rheum,2000,43(3):593-598.
[27] KOOL J,RUSELER-VAN E J G,VAN LIESHOUT L M,et al.Induction of arthritis in rats by soluble peptidoglycan-polysaccharide complexes produced by human intestinal flora[J].Arthritis Rheum,1991,34(12):1611-1616.
[28] SCHRIJVER I A,MELIEF M J,TAK P P,et al.Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines[J].Arthritis Rheum,2000,43(10):2160-2168.
[29] TAKIISHI T,KORF H,VAN BELLE T L,et al.Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified lactococcus lactis in mice[J].J Clin Invest,2012,122(5):1717-1725.
[30] METCALFE D,HARTE A L,ALETRARI M O,et al.Does endotoxaemia contribute to osteoarthritis in obese patients?[J].Clin Sci(Lond),2012,123(11):627-634.
[31] COLLINS K H,PAUL H A,REIMER R A,et al.Relationship between inflammation,the gut microbiota,and metabolic osteoarthritis development:studies in a rat model[J].Osteoarthritis Cartilage,2015,23(11):1989-1998.
[32] HUANG Z Y,STABLER T,PEI F X,et al.Both systemic and local lipopolysaccharide(LPS)burden are associated with knee OA severity and inflammation[J].Osteoarthritis Cartilage,2016,24(10):1769-1775.
[33] HAGLUND L,BERNIER S M,ONNERFJORD P,et al.Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage[J].Matrix Biol,2008,27(2):107-118.
[34] VIJAY-KUMAR M,AITKEN J D,CARVALHO F A,et al.Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5[J].Science,2010,328(5975):228-231.
[35] CHASSAING B,GEWIRTZ A T.Gut microbiota,low-grade inflammation,and metabolic syndrome[J].Toxicol Pathol,2014,42(1):49-53.
[36] 羅淦,湯樣華,康儀,等.骨關(guān)節(jié)炎相關(guān)信號(hào)通路的研究進(jìn)展[J].中醫(yī)正骨,2019,31(5):31-37.
[37] VELLOSO L A,FOLLI F,SAAD M J.TLR4 at the Crossroads of nutrients,gut microbiota,and metabolic inflammation[J].Endocr Rev,2015,36(3):245-271.
[38] KIM H A,CHO M L,CHOI H Y,et al.The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes[J].Arthritis Rheum,2006,54(7):2152-2163.
[39] KYBURZ D,RETHAGE J,SEIBL R,et al.Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by Toll-like receptor signaling[J].Arthritis Rheum,2003,48(3):642-650.
[40] XU X L,LIU X D,YANG Y C,et al.Resveratrol inhibits the development of obesity-related osteoarthritis via the TLR4 and PI3K/Akt signaling pathways[J].Connect Tissue Res,2019,60(6):571-582.
[41] 吳鑫杰,譚明生,移平.NOD樣受體蛋白3炎性小體在創(chuàng)傷性脊髓損傷中的作用[J].中醫(yī)正骨,2019,31(2):31-35.
[42] MCALLISTER M J,CHEMALY M,EAKIN A J,et al.NLRP3 as a potentially novel biomarker for the management of osteoarthritis[J].Osteoarthritis Cartilage,2018,26(5):612-619.
[43] HENAO-MEJIA J,ELINAV E,JIN C,et al.Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity[J].Nature,2012,482(7384):179-185.
[44] LAMKANFI M,KANNEGANTI T D.The inflammasome:a remote control for metabolic syndrome[J].Cell Res,2012,22(7):1095-1098.
[45] CLAVIJO-CORNEJO D,MARTINEZ-FLORES K,SILVA-LUNA K,et al.The overexpression of NALP3 inflammasome in knee osteoarthritis is associated with synovial membrane prolidase and NADPH oxidase 2[J].Oxid Med Cell Longev,2016,2016:1472567.
[46] ZHAO L R,XING R L,WANG P M,et al.NLRP1 and NLRP3 inflammasomes mediate LPS/ATP induced pyroptosis in knee osteoarthritis[J].Mol Med Rep,2018,17(4):5463-5469.
[47] SUN Y,LIU W,ZHANG H,et al.Curcumin prevents osteoarthritis by inhibiting the activation of inflammasome NLRP3[J].J Interferon Cytokine Res,2017,37(10):449-455.
相似文獻(xiàn)/References:
[1]孟維娜,明立功,王新德,等.關(guān)節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[2]明立功,孟維娜,王新德,等.腓骨近端截骨治療內(nèi)側(cè)間室膝骨關(guān)節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[3]張杰,王人彥,張玉柱.膝骨關(guān)節(jié)炎的治療進(jìn)展[J].中醫(yī)正骨,2015,27(10):68.
[4]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關(guān)節(jié)炎早期疼痛癥狀的療效評(píng)價(jià)[J].中醫(yī)正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):9.
[5]王建武,黨建軍,李強(qiáng),等.四聯(lián)療法治療膝骨關(guān)節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[6]劉紅娟,郭會(huì)利,郭樹(shù)農(nóng).云克聯(lián)合中藥治療膝骨關(guān)節(jié)炎的護(hù)理[J].中醫(yī)正骨,2015,27(08):75.
[7]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關(guān)節(jié)炎中醫(yī)臨床科研范式
和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[8]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補(bǔ)腎柔肝藥和活血祛風(fēng)藥治療
骨關(guān)節(jié)炎作用方式的計(jì)算機(jī)模擬比較[J].中醫(yī)正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補(bǔ)腎柔肝)drugs versus Huoxue Qufeng(活血祛風(fēng))drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):6.
[9]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關(guān)節(jié)炎的作用機(jī)制研究[J].中醫(yī)正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):15.
[10]梅其杰,袁長(zhǎng)深,段戡,等.壯藥骨痹方燙熨聯(lián)合運(yùn)動(dòng)療法治療膝骨關(guān)節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):27.